Tokushima, Japan

Masahiro Ito



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masahiro Ito: Innovator in Cephem Compounds

Introduction

Masahiro Ito is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephem compounds. With a total of two patents to his name, Ito's work has had a considerable impact on antimicrobial research.

Latest Patents

Ito's latest patents include a process for the production of 3-alkenylcephem compounds. This process involves preparing 7-amino-3-[(E/Z)-2-(4-methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid and its alkali metal salt. The innovation is characterized by treating an aqueous solution of the alkali metal salt with a high porous polymer and/or active carbon to improve the content of the desired compounds. Another patent focuses on the cephem compound and the process for producing it, which is crucial for antimicrobial applications.

Career Highlights

Throughout his career, Masahiro Ito has worked with prominent companies in the pharmaceutical industry. He has been associated with Otsuka Kagaku Kabushiki Kaisha and Taiho Pharmaceutical Company Limited. His work in these organizations has allowed him to develop and refine his innovative processes.

Collaborations

Ito has collaborated with notable colleagues, including Hiroshi Akagi and Masaru Yasui. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Masahiro Ito's contributions to the field of cephem compounds and antimicrobial research highlight his role as an influential inventor. His innovative processes and collaborations have paved the way for advancements in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…